Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
02/2012
02/28/2012US8124625 Method of enhancing the expression of apolipoprotein AI using olefin derivatives
02/28/2012CA2514220C Ep4 receptor antagonists
02/23/2012WO2012023947A1 Bicarbazole compounds for oleds
02/23/2012WO2012023582A1 4-isopropylphenyl glucitol compound
02/23/2012WO2012022794A1 Pyridazin derivatives as antagonists of the bradykinin b1 receptor
02/23/2012WO2012022265A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012WO2012003405A4 Sgc stimulators
02/23/2012WO2011126903A3 Multisubstituted aromatic compounds as inhibitors of thrombin
02/23/2012WO2011115513A3 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation
02/23/2012US20120046464 Cyclic Diones and Their Use as Insecticides, Acaricides and/or Fungicides
02/23/2012US20120046334 Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
02/23/2012US20120046320 Beta- and gamma-diketones and gamma-hydroxyketones as wnt/beta-catenin signaling pathway activators
02/23/2012US20120046288 Hydrazonamide Compounds That Modulate Hsp90 Activity
02/23/2012US20120046277 Benzofuran derivatives
02/23/2012US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2012US20120046269 Novel Amino Azaheterocyclic Carboxamides
02/23/2012US20120046268 Substituted piperidines as Par-1 Antagonists
02/23/2012US20120045454 2,4-pyrimidinediamine compounds and their uses
02/23/2012US20120043531 Compound for organic optoelectronic device, organic light emitting diode including the same, and display device including the light emitting diode
02/23/2012CA2808543A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012CA2807419A1 Diketones and hydroxyketones as catenin signaling pathway activators
02/23/2012CA2807086A1 Disubstituted tetrahydrofuranyl compounds as antagonists of the bradykinin b1 receptor
02/22/2012EP2420495A1 Novel derivatives useful as antiviral agents
02/22/2012EP2420491A1 3 , 5-substitued piperidine compounds as renin inhibitors
02/22/2012EP2419425A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
02/22/2012EP2419419A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
02/22/2012EP2419418A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
02/22/2012EP2419408A1 3-aryl or heteroaryl-substituted indole derivative
02/22/2012EP2419405A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
02/22/2012EP2310382B1 Amidophenoxyindazoles useful as inhibitors of c-met
02/22/2012EP1995240B1 Quinolone derivative or pharmaceutically acceptable salt thereof
02/22/2012EP1963286B1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same
02/22/2012EP1778637B1 FKBP-binding composition and pharmaceutical use thereof
02/22/2012EP1644363B1 Triheterocyclic compounds, compositions, and methods for treating cancer
02/22/2012CN102361863A Novel bicyclic antibiotics
02/22/2012CN102361857A Novel cyclic benzimidazole derivatives useful anti-diabetic agents
02/22/2012CN102361846A Novel herbicides
02/22/2012CN102358738A 2,4-pyrimidinediamine compounds and uses of treating or preventing autoimmune diseases thereof
02/22/2012CN102358737A Preparation method of 8-amino-2-(1H-tetrazol-5-yl)-chromen hydrochloride
02/22/2012CN101492416B 影响葡糖激酶的化合物 Effect of compound of glucokinase
02/21/2012US8119808 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
02/21/2012US8119797 Production method
02/21/2012US8119687 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
02/21/2012US8119678 Compounds, compositions and methods
02/21/2012US8119665 Aryl imidazoles and related compounds as C5a receptor modulators
02/21/2012US8119664 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
02/21/2012US8119631 Inhibitors of interleukin-1β converting enzyme
02/21/2012US8119630 Benzodiazepine derivatives and pharmaceutical compositions containing them
02/21/2012US8119627 Heterocyclic compounds as inhibitors of 17beta-HSD3
02/21/2012US8119626 Oxime derivative and preparations thereof
02/21/2012US8119624 Fused phenyl amido heterocyclic compounds
02/21/2012CA2682254C 1,3-oxathiolane nucleoside analogues
02/21/2012CA2534105C Aminoquinoline derivatives and their use as adenosine a3 ligands
02/21/2012CA2478542C Aminoindazole derivatives, their method of preparation and intermediaries of this process as medicines and pharmaceutical compositions containing same
02/21/2012CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
02/16/2012WO2012021830A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors
02/16/2012WO2012021591A1 Hepatitis c virus inhibitors
02/16/2012WO2012020813A1 Fused-ring pyrrolidine derivative
02/16/2012WO2012020787A1 Malignant lymphoma therapeutic agent
02/16/2012WO2012020786A1 Pharmaceutical composition
02/16/2012WO2012020780A1 Heterocyclic compound and use thereof
02/16/2012WO2012020762A1 Hetero ring compound
02/16/2012WO2012020749A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
02/16/2012WO2012020742A1 Novel heterocyclic derivatives and pharmaceutical composition containing same
02/16/2012WO2012020725A1 Heterocyclic derivative having npy y5 receptor antagonism
02/16/2012WO2012020567A1 Acyl piperazine derivatives as ttx-s blockers
02/16/2012WO2012019966A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/16/2012WO2012019430A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
02/16/2012WO2012019315A1 Novel trpv3 modulators
02/16/2012WO2011163610A3 Antimicrobial agents
02/16/2012WO2011133751A9 Process of producing cycloalkylcarboxamido-indole compounds
02/16/2012US20120041215 Protease inhibitor precursor synthesis
02/16/2012US20120041199 Process for the Preparation of Doxazosin and Salts Thereof
02/16/2012US20120041019 Protease inhibitors
02/16/2012US20120041011 Substituted benzofused derivatives and their use as vanilloid receptor ligands
02/16/2012US20120040996 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof
02/16/2012US20120040995 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
02/16/2012US20120040985 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
02/16/2012US20120040977 Inhibitors of hcv ns5a
02/16/2012US20120040968 Diamino heterocyclic carboxamide compound
02/16/2012US20120040966 Anti-viral compounds, treatment, and assay
02/16/2012US20120040964 N-substituted piperidines and their use as pharmaceuticals
02/16/2012US20120040962 Fused ring inhibitors of hepatitis c
02/16/2012US20120040957 Novel Bicyclic Antibiotics
02/16/2012US20120040955 Fluoro substituted pyrimidine compounds as jak3 inhibitors
02/16/2012US20120040952 Azetidines as histamine h3 receptor antagonists
02/16/2012US20120040935 Compositions useful as inhibitors of voltage-gated ion channels
02/16/2012US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators
02/16/2012US20120040897 Novel derivatives of acyl cyanopyrrolidines
02/16/2012US20120040020 Compounds useful as inhibitors of atr kinase
02/16/2012CA2808435A1 Heterocyclic compound
02/16/2012CA2808061A1 Hepatitis c virus inhibitors
02/16/2012CA2807947A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
02/16/2012CA2807538A1 Novel trpv3 modulators
02/16/2012CA2805867A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/15/2012EP2418207A1 Sulfone compounds which modulate the CB2 receptor
02/15/2012EP2418206A2 Benzodiazepine derivatives useful in the treatment of autoimmune disorders
02/15/2012EP2418205A1 Pyrimidine urea derivatives as kinase inhibitors
02/15/2012EP2418203A1 Cyclic compound having substituted phenyl group
02/15/2012EP2418202A1 New compounds
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 694